Fortis Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.90 Cr
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2017
- Revenue Growth -99.16%
- Profit Growth -118.70%
- Ebitda -216.16%
- Net Worth -91.22%
- Total Assets -70.98%
About Fortis Clinical Research
Fortis Clinical Research Limited (FCRL) is Strike Off company established on 29 Mar 2005 with its office registered at South Delhi, Delhi, India and has been running since 19 Year, 11 Months with a paid up capital of 4.90 Cr. According to MCA records, 3 Directors are linked to this company as of 21 Apr 2024.
Company Details
- Location
South Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100DL2005PLC134482
- Company No.
134482
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2005
- Date of AGM
25 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
What products or services does Fortis Clinical Research Limited offer?
Fortis Clinical Research Limited offers a wide range of products and services, including Graduation & High Education Programs, Medical Educational Service, Bioequivalence Study.
Who are the key members and board of directors at Fortis Clinical Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivinder Singh  | Director | 25-Jul-2005 | Current |
| Malvinder Singh | Director | 25-Jul-2005 | Current |
| Harpal Singh | Director | 18-Jul-2005 | Current |
Financial Performance of Fortis Clinical Research.
Fortis Clinical Research Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 99.16% decrease. The company also saw a substantial fall in profitability, with a 118.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 91.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fortis Clinical Research?
In 2017, Fortis Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Impact Projects Private LimitedHarpal Singh is a mutual person
Oscar Investments LimitedShivinder Singh and Malvinder Singh are mutual person
- Rhc Holding Private Limited
Shivinder Singh and Malvinder Singh are mutual person
- Finserve Shared Services Private Limited
Shivinder Singh and Malvinder Singh are mutual person
- Shimal Healthcare Private Limited
Shivinder Singh and Malvinder Singh are mutual person
- White Feather Estates Private Limited
Malvinder Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fortis Clinical Research?
Fortis Clinical Research has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fortis Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortis Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Fortis Clinical Research
Recent activity within the organization
- Annual General Meeting
Fortis Clinical Research Limited last Annual general meeting of members was held on 25 Sep 2017 as per latest MCA records.
- Balance Sheet
Fortis Clinical Research Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Delhi.
- Director Appointment
Shivinder Mohan Singh was appointed as a Director was appointed as a Director on 25 Jul 2005 & has been associated with this company since 19 years 8 months .
- Director Appointment
Malvinder Mohan Singh was appointed as a Director was appointed as a Director on 25 Jul 2005 & has been associated with this company since 19 years 8 months .
- Director Appointment
Harpal Singh was appointed as a Director was appointed as a Director on 18 Jul 2005 & has been associated with this company since 19 years 8 months .
- Company Incorporation
Fortis Clinical Research Limited was registered on 29 Mar 2005 with Roc Delhi & aged 19 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Fortis Clinical Research Limited?
Fortis Clinical Research Limited was incorporated on 29 Mar 2005.
What is authorized share capital and paid-up capital of Fortis Clinical Research Limited?
The authorized share capital of Fortis Clinical Research Limited is ₹ 5.00 Cr and paid-up capital is ₹ 4.90 Cr.
Who are the current board members & directors of Fortis Clinical Research Limited?
Currently 3 directors are associated with Fortis Clinical Research Limited.
- Shivinder Mohan Singh
- Malvinder Mohan Singh
- Harpal Singh
What is the registered address of Fortis Clinical Research Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Fortis Clinical Research Limited is Prius Platinum Ground Floor, D3 District Center Saket, Delhi, India, 110017.
What is the corporate identification number (CIN) and company number of Fortis Clinical Research Limited?
The corporate identification number (CIN) of Fortis Clinical Research Limited is U73100DL2005PLC134482 and the company number is 134482 as per Ministry of Corporate Affairs (MCA).
What is the official website of Fortis Clinical Research Limited?
The Official website of Fortis Clinical Research Limited is https://www.cmocro.com
What has been the recent revenue trend for Fortis Clinical Research Limited?
According to the financial reports for the fiscal year 2017, the revenue trend for Fortis Clinical Research Limited has fallen by -99.16%.
What change has been observed in the net worth of Fortis Clinical Research Limited, and by what percentage?
The financial reports for the fiscal year 2017 indicates that The net worth of Fortis Clinical Research Limited has experienced an downturn of -91.22%.
When was the last Balance Sheet of Fortis Clinical Research Limited filed with the ROC?
The most recent Balance Sheet for Fortis Clinical Research Limited was filed with the ROC on 31 Mar 2017.
People also Viewed
VK
Vinay KaulDirectorAP
Anil PanwarDirector